FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ANTI-DRUG ANTIBODIESTOTUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; A TWOYEAR FOLLOW-UP STUDY
dc.authorwosid | Solmaz, Dilek/B-1448-2016 | |
dc.contributor.author | Ediboglu, E. Durak | |
dc.contributor.author | Solmaz, D. | |
dc.contributor.author | Kabadayi, G. | |
dc.contributor.author | Ozmen, M. | |
dc.contributor.author | Cinar, M. | |
dc.contributor.author | Sargin, G. | |
dc.contributor.author | Karadag, O. | |
dc.date.accessioned | 2023-01-12T20:02:57Z | |
dc.date.available | 2023-01-12T20:02:57Z | |
dc.date.issued | 2021 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.identifier.doi | 10.1136/annrheumdis-2021-eular.2215 | |
dc.identifier.endpage | 727 | en_US |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issn | 1468-2060 | |
dc.identifier.issn | 0003-4967 | en_US |
dc.identifier.issn | 1468-2060 | en_US |
dc.identifier.startpage | 727 | en_US |
dc.identifier.uri | https://doi.org/10.1136/annrheumdis-2021-eular.2215 | |
dc.identifier.uri | https://hdl.handle.net/11454/77642 | |
dc.identifier.volume | 80 | en_US |
dc.identifier.wos | WOS:000692649600594 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bmj Publishing Group | en_US |
dc.relation.ispartof | Annals Of The Rheumatic Diseases | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ANTI-DRUG ANTIBODIESTOTUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; A TWOYEAR FOLLOW-UP STUDY | en_US |
dc.type | Conference Object | en_US |